CEL-SCI raises $7.2M in public offering of 6M shares at $1.20/share

CEL SCI CORP

Gross proceeds of $7.2 million from 6,000,000 shares at $1.20 per share.
Net proceeds to fund continued development of Multikine, working capital, and general corporate purposes.
ThinkEquity as sole placement agent; 7.0% cash fee plus up to $150,000 expense reimbursement.
Lock-up: Company 30-day issuance ban; directors/officers 45-day sale ban from May 11, 2026.
Offering closed May 13, 2026; registered under effective S-1 (333-295168).

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.96

CEL SCI CORP entered into Placement Agency Agreement with ThinkEquity LLC valued at $7,200,000 gross proceeds from offering of 6,000,000 shares at $1.20 per share (effective 2026-05-11).

Action: entry
Agreement: underwriting
Counterparty: ThinkEquity LLC
Value: $7,200,000 gross proceeds from offering of 6,000,000 shares at $1.20 per share
Effective: 2026-05-11

Exact text from the filing

On May 11, 2026, CEL-SCI Corporation, a Colorado corporation (the “Company”), entered into a Placement Agency Agreement with ThinkEquity LLC (the “Placement Agent”) relating to the sale and issuance of 6,000,000 shares of the Company’s common stock, at an offering price of $1.20 per share (the “Shares”).

View on SEC.gov

800 material agreements filed in the last 30 days. Browse all material agreements →

CEL SCI CORP filing history →

Source: SEC EDGAR

accession 0001654954-26-004823

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.